The tweet was deleted by the author.
But we saved everything 🙂.
Zymeworks management will participate in the Needham 25th Annual Virtual Healthcare Conference in April. The company is set to present to investors and hold virtual one-on-one meetings, with a formal presentation scheduled for April 15 at 10:15 am.
This participation underscores Zymeworks commitment to engaging investors and updating the market on its activities. Further details about the conference agenda are available on the company’s website.
Earlier this year, Zymeworks executives outlined developments in antibody therapeutics and ADC discovery at the ESMO Congress in Paris. The company also presented new clinical and preclinical antibody-drug conjugate program data targeting cancer research at the AACR Annual Meeting. These activities highlight an ongoing strategy of sharing research updates at major industry conferences.